Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells
Crossref DOI link: https://doi.org/10.1038/aps.2017.123
Published Online: 2017-09-07
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jiang, Xiao-Ming
Xu, Yu-Lian
Huang, Mu-Yang
Zhang, Le-Le
Su, Min-Xia
Chen, Xiuping
Lu, Jin-Jian
Text and Data Mining valid from 2017-09-07
Article History
Received: 25 April 2017
Accepted: 18 June 2017
First Online: 7 September 2017